[EN] INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF<br/>[FR] INHIBITEURS DE FACTEURS DU COMPLÉMENT ET LEURS UTILISATIONS
申请人:ANNEXON INC
公开号:WO2022020244A1
公开(公告)日:2022-01-27
Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
揭示了式I和II的化合物及其药用盐。还披露了使用此处披露的化合物治疗神经退行性疾病、炎症性疾病、自身免疫疾病、眼科疾病或代谢性疾病的方法。